Denovo Bioinnovations Pvt. Ltd. has secured ₹1.96 Crore from Campus Angels Network to advance its surgical robotics innovations. Founded by Dr. Nikhil Mamoria, Denovo develops cutting-edge wound ...
People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower rates of hospital readmission, wound re-opening and hematoma after surgery ...
Denovo's approach leverages a unique "razor-razor blade" revenue model, combining reusable devices with disposable cartridges to create a sustainable and scalable business framework. The company is ...
Negative Pressure Wound Therapy IndustryThe global negative pressure wound therapy (NPWT) market is projected to grow from an estimated valuation of USD 6.5 billion in 2023 to USD 10.8 billion by 2033 ...